Dyne Therapeutics | Evaluate

Big readouts ahead for small biotechs

Nash data are due for Terns and Inventiva, as Marinus aims to expand its rare disease offering.

Tofersen adcom raises hopes of even more FDA flexibility

September 27, 2022

Clinical hold weakens investors’ bond with Avidity

January 24, 2022

Early-stage US clinical holds spread

October 01, 2020

Another huge quarter for biotech flotations

Drug developers raised a record $4.5bn in IPOs in the third quarter, and investor support for biopharma shows little sign of waning.